Bjorg Asbjornsdottir
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Single-Arm, Treat-to-Target Clinical Trial.
Journal: Diabetes technology & therapeutics
Published: March 05, 2025
Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: September 18, 2024
Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials.
Journal: Diabetes, obesity & metabolism
Published: May 29, 2024
Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1-5 trials.
Journal: Diabetes, obesity & metabolism
Published: February 12, 2024
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1.
Journal: The lancet. Diabetes & endocrinology
Published: February 07, 2024
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.
Journal: Diabetes care
Published: November 09, 2023
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial.
Journal: Lancet (London, England)
Published: December 16, 2022
Home Blood Pressure for the Prediction of Preeclampsia in Women With Preexisting Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 23, 2022
Falling Insulin Requirement in Pregnant Women With Diabetes Delivering Preterm: Prevalence, Predictors, and Consequences.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 11, 2022
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: November 01, 2021
Prevalence and severity of diabetic retinopathy in pregnant women with diabetes-time to individualize photo screening frequency.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: October 21, 2021
Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study.
Journal: Diabetes care
Published: June 04, 2021
Last Updated: 09/26/2026